LOW DOSE POSTTRANSPLANTATION CYCLOPHOSPHAMIDE CAN ENHANCE THE PROTECTIVE EFFECT OF ATG /G-CSF ON GVHD: RESULTS OF A PHASE II PROSPECTIVE TRIAL

被引：0
|
作者：
Wang, Y. [1 ]
Chang, Y. -J. [1 ]
Huang, X. -J. [1 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1517
引用
收藏
页码：618 / 619
页数：2
相关论文
共 50 条
  • [31] A phase II multicenter clinical trial of high-dose bi-weekly THP-COP with G-CSF support (HDBW-TCOP(G)) for non-Hodgkin's lymphoma.
    Nikkuni, K
    Aoki, S
    Tsukada, N
    Takizawa, J
    Takahashi, M
    Takai, K
    Sanada, M
    Nomoto, N
    Aizawa, Y
    BLOOD, 2001, 98 (11) : 136A - 136A
  • [32] Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial
    Gleason, John F., Jr.
    Kudrimoti, Mahesh
    Van Meter, Emily M.
    Mohiuddin, Mohammed
    Regine, William F.
    Valentino, Joseph
    Kenady, Daniel
    Arnold, Susanne M.
    JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (01) : 35 - 42
  • [33] The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
    Charlotte M. Huijts
    Sinéad M. Lougheed
    Zuhir Bodalal
    Carla M. van Herpen
    Paul Hamberg
    Metin Tascilar
    John B. Haanen
    Henk M. Verheul
    Tanja D. de Gruijl
    Hans J. van der Vliet
    Cancer Immunology, Immunotherapy, 2019, 68 : 503 - 515
  • [34] The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
    Huijts, Charlotte M.
    Lougheed, Sinead M.
    Bodalal, Zuhir
    van Herpen, Carla M.
    Hamberg, Paul
    Tascilar, Metin
    Haanen, John B.
    Verheul, Henk M.
    de Gruijl, Tanja D.
    van der Vliet, Hans J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 503 - 515
  • [35] Use of G-CSF in Patients with Severe Aplastic Anemia Treated with ATG and Cyclosporine Increases Neutrophils and Decreases Infection Rates and Hospitalization Days but Does Not Improve Long-Term Outcome: Results of a Prospective, Randomized Clinical Trial of the EBMT.
    Tichelli, Andre
    Schrezenmeier, Hubert
    Socie, Gerard
    Marsh, Judith
    Bacigalupo, Andrea
    Duehrsen, UIrich
    Franzke, Anke
    Hallek, Michael
    Thiel, Eckhard
    Wilhelm, Martin
    Hoechsmann, Britta
    Barrois, Alain
    Champion, Kim
    Passweg, Jakob R.
    BLOOD, 2009, 114 (22) : 205 - 205
  • [36] Low-dose fractionated radiation and chemotherapy prior to definitive chemoradiation in locally advanced carcinoma of the uterine cervix: Results of a prospective phase II clinical trial
    Das, Saikat
    Subhashini, J.
    Reddy, Jeba Karunya Rami
    KantiPal, Suparna
    Isiah, Rajesh
    Oommen, Regi
    GYNECOLOGIC ONCOLOGY, 2015, 138 (02) : 292 - 298
  • [37] Randomized phase II trial for primary induction therapy in AML using sequential high dose cytosine arabinoside (AraC) and mitoxantrone (S-HAM) and pegylated G-CSF for shortening of therapy-induced neutropenia
    Braess, J.
    Fiegl, M.
    Reichle, A.
    Woermann, B.
    Oruzio, D.
    Staib, P.
    Berdel, W.
    Heinecke, A.
    Hiddemann, W.
    ANNALS OF HEMATOLOGY, 2006, 85 : 28 - 30
  • [38] A phase II study with decitabine, low-dose cytarabine and G-CSF priming in high-risk myelodysplastic syndromes, refractory/relapsed acute myelogenous leukemia or acute myeloid leukemia in patients with significant comorbidities
    Butera, J.
    Winer, E.
    Wang, C.
    Castillo, J. J.
    Thomas, A. G.
    Safran, H.
    Mega, A. E.
    Colvin, G. A.
    Rathore, B.
    Quesenberry, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [39] G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial
    Halpern, Anna B.
    Huebner, Emily M.
    Othus, Megan
    Scott, Bart L.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Gardner, Kelda M.
    Buckley, Sarah A.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2017, 130
  • [40] Low-dose Radiation Therapy in the Management of COVID-19 Pneumonia (LOWRAD-Cov19). Final results of a prospective phase I-II trial
    Sanmamed, Noelia
    Alcantara, Pino
    Gomez, Sara
    Bustos, Ana
    Cerezo, Elena
    Gaztanaga, Miren
    Doval, Anxela
    Corona, Juan
    Rodriguez, Gabriel
    Cabello, Noemi
    Duffort, Mercedes
    Ortuno, Francisco
    de Castro, Javier
    Lopez, Amanda
    Fuentes, Manuel
    Alvaro, Sanz J.
    Vazquez, Manuel
    RADIOTHERAPY AND ONCOLOGY, 2022, 171 : 25 - 29
12345